BACKGROUND: The use of specific COX-2 inhibitors in cancer prevention has been associated with higher risk of acute coronary syndrome (ACS) and myocardial infarction. The aim of this study was to investigate if the polymorphisms COX2 T8473C (rs5275), and COX2 A-1195G (rs689466), which modify the enzyme levels of COX-2, were associated with risk of ACS and if alcohol intake, smoking, and use of NSAID would modify the associations. We also wanted to investigate associations with blood lipid levels. METHODS: A case-cohort study including 1031 ACS cases and a sub-cohort of 1703 persons was nested within the population-based prospective study Diet, Cancer and Health of 57,053 individuals aged 55-64 at recruitment 1993-1997. RESULTS: Male variant allele carriers of COX-2 T8473C were at lower risk of ACS (IRR=0.75, CI=0.61-0.93, p=0.008) than homozygous wildtype carriers. There were no statistically significant interactions between genotypes and alcohol intake, smoking and NSAID use in relation to risk of ACS. Among males, there was interaction between COX-2 T8473C and alcohol in relation to total cholesterol, non-HDL cholesterol and LDL levels (p for interaction: 0.003, 0.007 and 0.01, respectively), such that variant allele carriers with low alcohol intake had the lowest lipid levels. No statistically significant associations were observed in females. CONCLUSION: This study suggests that genetically determined COX-2 levels are associated with risk of ACS and blood lipid levels among males. No consistent associations were found for females.
BACKGROUND: The use of specific COX-2 inhibitors in cancer prevention has been associated with higher risk of acute coronary syndrome (ACS) and myocardial infarction. The aim of this study was to investigate if the polymorphisms COX2T8473C (rs5275), and COX2 A-1195G (rs689466), which modify the enzyme levels of COX-2, were associated with risk of ACS and if alcohol intake, smoking, and use of NSAID would modify the associations. We also wanted to investigate associations with blood lipid levels. METHODS: A case-cohort study including 1031 ACS cases and a sub-cohort of 1703 persons was nested within the population-based prospective study Diet, Cancer and Health of 57,053 individuals aged 55-64 at recruitment 1993-1997. RESULTS: Male variant allele carriers of COX-2T8473C were at lower risk of ACS (IRR=0.75, CI=0.61-0.93, p=0.008) than homozygous wildtype carriers. There were no statistically significant interactions between genotypes and alcohol intake, smoking and NSAID use in relation to risk of ACS. Among males, there was interaction between COX-2T8473C and alcohol in relation to total cholesterol, non-HDL cholesterol and LDL levels (p for interaction: 0.003, 0.007 and 0.01, respectively), such that variant allele carriers with low alcohol intake had the lowest lipid levels. No statistically significant associations were observed in females. CONCLUSION: This study suggests that genetically determined COX-2 levels are associated with risk of ACS and blood lipid levels among males. No consistent associations were found for females.
Authors: Patricia McGettigan; Lisa F Lincz; John Attia; Patrick McElduff; Linda Bissett; Roseanne Peel; Barrie Stokes; Stephen Hancock; Kim Henderson; Michael Seldon; David Henry Journal: Br J Clin Pharmacol Date: 2011-10 Impact factor: 4.335
Authors: Ulla Vogel; Majken K Jensen; Karen Margrete Due; Eric B Rimm; Håkan Wallin; Michael R S Nielsen; Anne-Pernille T Pedersen; Anne Tjønneland; Kim Overvad Journal: Atherosclerosis Date: 2011-06-17 Impact factor: 5.162
Authors: Marina Korotkova; Nina A Daha; Maria Seddighzadeh; Bo Ding; Anca I Catrina; Staffan Lindblad; Tom W J Huizinga; Rene E M Toes; Lars Alfredsson; Lars Klareskog; Per-Johan Jakobsson; Leonid Padyukov Journal: Eur J Hum Genet Date: 2011-03-30 Impact factor: 4.246
Authors: Stephanie Ross; John Eikelboom; Sonia S Anand; Niclas Eriksson; Hertzel C Gerstein; Shamir Mehta; Stuart J Connolly; Lynda Rose; Paul M Ridker; Lars Wallentin; Daniel I Chasman; Salim Yusuf; Guillaume Paré Journal: Eur Heart J Date: 2014-05-05 Impact factor: 29.983
Authors: Sarah M Rausch; Brian D Gonzalez; Matthew M Clark; Christi Patten; Sara Felten; Heshan Liu; Yafei Li; Jeff Sloan; Ping Yang Journal: Lung Cancer Date: 2012-03-29 Impact factor: 5.705
Authors: Kati Lähteelä; Tarja Kunnas; Leo-Pekka Lyytikäinen; Nina Mononen; Leena Taittonen; Tomi Laitinen; Johannes Kettunen; Markus Juonala; Nina Hutri-Kähönen; Mika Kähönen; Jorma S Viikari; Olli T Raitakari; Terho Lehtimäki; Seppo T Nikkari Journal: BMC Med Genet Date: 2012-07-02 Impact factor: 2.103
Authors: Jakob Gerhard Stegger; Erik Berg Schmidt; Tina Landsvig Berentzen; Anne Tjønneland; Ulla Vogel; Eric Rimm; Thorkild I A Sørensen; Kim Overvad; Majken K Jensen Journal: PLoS One Date: 2013-05-09 Impact factor: 3.240